Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia
Geyh, S, Rodríguez-Paredes, M, Jäger, P, Khandanpour, C, Cadeddu, R-P, Gutekunst, J, Wilk, C M, Fenk, R, Zilkens, C, Hermsen, D, Germing, U, Kobbe, G, Lyko, F, Haas, R, Schroeder, T
Published in Leukemia (01.03.2016)
Published in Leukemia (01.03.2016)
Get full text
Journal Article
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
Schroeder, T, Czibere, A, Platzbecker, U, Bug, G, Uharek, L, Luft, T, Giagounidis, A, Zohren, F, Bruns, I, Wolschke, C, Rieger, K, Fenk, R, Germing, U, Haas, R, Kröger, N, Kobbe, G
Published in Leukemia (01.06.2013)
Published in Leukemia (01.06.2013)
Get full text
Journal Article
Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells
Geyh, S, Öz, S, Cadeddu, R-P, Fröbel, J, Brückner, B, Kündgen, A, Fenk, R, Bruns, I, Zilkens, C, Hermsen, D, Gattermann, N, Kobbe, G, Germing, U, Lyko, F, Haas, R, Schroeder, T
Published in Leukemia (01.09.2013)
Published in Leukemia (01.09.2013)
Get full text
Journal Article
Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials
Platzbecker, U., Fenaux, P., Adès, L., Giagounidis, A., Santini, V., van de Loosdrecht, A.A., Bowen, D., de Witte, T., Garcia-Manero, G., Hellström-Lindberg, E., Germing, U., Stauder, R., Malcovati, L., Sekeres, Mikkael A., Steensma, David P., Gloaguen, S.
Published in Blood (07.03.2019)
Published in Blood (07.03.2019)
Get full text
Journal Article
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group
Westers, T M, Ireland, R, Kern, W, Alhan, C, Balleisen, J S, Bettelheim, P, Burbury, K, Cullen, M, Cutler, J A, Della Porta, M G, Dräger, A M, Feuillard, J, Font, P, Germing, U, Haase, D, Johansson, U, Kordasti, S, Loken, M R, Malcovati, L, te Marvelde, J G, Matarraz, S, Milne, T, Moshaver, B, Mufti, G J, Ogata, K, Orfao, A, Porwit, A, Psarra, K, Richards, S J, Subirá, D, Tindell, V, Vallespi, T, Valent, P, van der Velden, V H J, de Witte, T M, Wells, D A, Zettl, F, Béné, M C, van de Loosdrecht, A A
Published in Leukemia (01.07.2012)
Published in Leukemia (01.07.2012)
Get full text
Journal Article
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
Kuendgen, A., Nomdedeu, M., Tuechler, H., Garcia-Manero, G., Komrokji, R. S., Sekeres, M. A., Della Porta, M. G., Cazzola, M., DeZern, A. E., Roboz, G. J., Steensma, D. P., Van de Loosdrecht, A. A., Schlenk, R. F., Grau, J., Calvo, X., Blum, S., Pereira, A., Valent, P., Costa, D., Giagounidis, A., Xicoy, B., Döhner, H., Platzbecker, U., Pedro, C., Lübbert, M., Oiartzabal, I., Díez-Campelo, M., Cedena, M. T., Machherndl-Spandl, S., López-Pavía, M., Baldus, C. D., Martinez-de-Sola, M., Stauder, R., Merchan, B., List, A., Ganster, C., Schroeder, T., Voso, M. T., Pfeilstöcker, M., Sill, H., Hildebrandt, B., Esteve, J., Nomdedeu, B., Cobo, F., Haas, R., Sole, F., Germing, U., Greenberg, P. L., Haase, D., Sanz, G.
Published in Leukemia (01.03.2021)
Published in Leukemia (01.03.2021)
Get full text
Journal Article
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts
Mufti, Ghulam J, Bennett, John M, Goasguen, Jean, Bain, Barbara J, Baumann, Irith, Brunning, Richard, Cazzola, Mario, Fenaux, Pierre, Germing, Ulrich, Hellstrom-Lindberg, Eva, Jinnai, Itsuro, Manabe, Atsushi, Matsuda, Akira, Niemeyer, Charlotte M, Sanz, Guillermo, Tomonaga, Masao, Vallespi, Teresa, Yoshimi, Ayami
Published in Haematologica (01.11.2008)
Published in Haematologica (01.11.2008)
Get full text
Journal Article
Conference Proceeding
Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts
Kasprzak, A., Assadi, C., Nachtkamp, K., Rudelius, M., Haas, R., Giagounidis, A., Götze, K., Gattermann, N., Germing, U.
Published in Annals of hematology (01.01.2023)
Published in Annals of hematology (01.01.2023)
Get full text
Journal Article
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)
Della Porta, M G, Tuechler, H, Malcovati, L, Schanz, J, Sanz, G, Garcia-Manero, G, Solé, F, Bennett, J M, Bowen, D, Fenaux, P, Dreyfus, F, Kantarjian, H, Kuendgen, A, Levis, A, Cermak, J, Fonatsch, C, Le Beau, M M, Slovak, M L, Krieger, O, Luebbert, M, Maciejewski, J, Magalhaes, S M M, Miyazaki, Y, Pfeilstöcker, M, Sekeres, M A, Sperr, W R, Stauder, R, Tauro, S, Valent, P, Vallespi, T, van de Loosdrecht, A A, Germing, U, Haase, D, Greenberg, P L, Cazzola, M
Published in Leukemia (01.07.2015)
Published in Leukemia (01.07.2015)
Get full text
Journal Article
The WHO 2016 diagnostic criteria for Acute Myeloid leukemia with myelodysplasia related changes (AML-MRC) produce a very heterogeneous entity: A retrospective analysis of the FAB subtype RAEB-T
Kaivers, J., Peters, J., Rautenberg, C., Schroeder, T., Kobbe, G., Hildebrandt, B., Haas, R., Germing, U., Bennett, J.M.
Published in Leukemia research (01.01.2022)
Published in Leukemia research (01.01.2022)
Get full text
Journal Article
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis
Broséus, J, Alpermann, T, Wulfert, M, Florensa Brichs, L, Jeromin, S, Lippert, E, Rozman, M, Lifermann, F, Grossmann, V, Haferlach, T, Germing, U, Luño, E, Girodon, F, Schnittger, S
Published in Leukemia (01.09.2013)
Published in Leukemia (01.09.2013)
Get full text
Journal Article
Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin
LIM, Z. Y, KILLICK, S, GERMING, U, CAVENAGH, J, CULLIGAN, D, BACIGALUPO, A, MARSH, J, MUFTI, G. J
Published in Leukemia (01.07.2007)
Published in Leukemia (01.07.2007)
Get full text
Journal Article
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification
Nachtkamp, K., Strupp, C., Vukelja, M., Kasprzak, A., Haase, D., Ganster, C., Hildebrandt, B., Betz, B., Giagounidis, A., Aul, C., Blum, S., Hofmann, W. K., Pfeilstöcker, M., Valent, P., Lübbert, M., Seidl, M., Rudelius, M., Stauder, R., Krieger, O., Götze, K. S., Bobak, J., Kündgen, A., Schulz, F., Dietrich, S., Kobbe, G., Gattermann, N., Germing, U.
Published in Leukemia (01.02.2024)
Published in Leukemia (01.02.2024)
Get full text
Journal Article
Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study
Platzbecker, U, Braulke, F, Kündgen, A, Götze, K, Bug, G, Schönefeldt, C, Shirneshan, K, Röllig, C, Bornhäuser, M, Naumann, R, Neesen, J, Giagounidis, A, Hofmann, W-K, Ehninger, G, Germing, U, Haase, D, Wermke, M
Published in Leukemia (01.06.2013)
Published in Leukemia (01.06.2013)
Get full text
Journal Article
Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation
Schroeder, T, Fröbel, J, Cadeddu, R-P, Czibere, A, Dienst, A, Platzbecker, U, Bug, G, Uharek, L, Fenk, R, Germing, U, Kröger, N, Haas, R, Kobbe, G
Published in Leukemia (01.09.2013)
Published in Leukemia (01.09.2013)
Get full text
Journal Article
Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias
Schuler, E, Schroeder, M, Neukirchen, J, Strupp, C, Xicoy, B, Kündgen, A, Hildebrandt, B, Haas, R, Gattermann, N, Germing, U
Published in Leukemia research (01.12.2014)
Published in Leukemia research (01.12.2014)
Get full text
Journal Article
Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis
Kuendgen, A, Lauseker, M, List, A F, Fenaux, P, Giagounidis, A A, Brandenburg, N A, Backstrom, J, Glasmacher, A, Hasford, J, Germing, U
Published in Leukemia (01.05.2013)
Published in Leukemia (01.05.2013)
Get full text
Journal Article